top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Consumption of diet drinks in the United States, 2009-2010 / / Tala H.I. Fakhouri, Brian K. Kit, and Cynthia L. Ogden
Consumption of diet drinks in the United States, 2009-2010 / / Tala H.I. Fakhouri, Brian K. Kit, and Cynthia L. Ogden
Autore Fakhouri Tala H. I.
Pubbl/distr/stampa Hyattsville, MD : , : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, , 2012
Descrizione fisica 1 online resource (7 pages) : color illustrations
Collana NCHS data brief
DHHS publication
Soggetto topico Sugar substitutes - United States
Nonnutritive sweeteners
Soft drinks - United States
Carbonated beverages - United States
Nutrition - United States
Soggetto genere / forma Statistics.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910704977203321
Fakhouri Tala H. I.  
Hyattsville, MD : , : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, , 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
In the matter of certain sucralose, sweeteners containing sucralose, and related intermediate compounds thereof [[electronic resource] ] : investigation no. 337-TA-604
In the matter of certain sucralose, sweeteners containing sucralose, and related intermediate compounds thereof [[electronic resource] ] : investigation no. 337-TA-604
Pubbl/distr/stampa Washington, DC : , : U.S. International Trade Commission, , [2010]
Descrizione fisica 1 online resource (2 volumes) : illustrations
Collana Publication
Soggetto topico Sucralose
Nonnutritive sweeteners
Patent infringement
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti In the matter of certain sucralose, sweeteners containing sucralose, and related intermediate compounds thereof
Record Nr. UNINA-9910700860103321
Washington, DC : , : U.S. International Trade Commission, , [2010]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Noncaloric sweeteners : their position in the sweetener industry
Noncaloric sweeteners : their position in the sweetener industry
Autore Ballinger Roy Arthur <1901-1982, >
Pubbl/distr/stampa Washington, D.C. : , : Economic Research Service, U.S. Department of Agriculture, , 1967
Descrizione fisica 1 online resource (iv, 20 pages) : illustrations
Collana Agricultural economic report
Soggetto topico Sugar substitutes
Nonnutritive sweeteners
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Noncaloric sweeteners
Record Nr. UNINA-9910715484303321
Ballinger Roy Arthur <1901-1982, >  
Washington, D.C. : , : Economic Research Service, U.S. Department of Agriculture, , 1967
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Stevioside [[electronic resource] ] : technology, applications, and health / / Sirshendu De, Sourav Mondal and Suvrajit Banerjee
Stevioside [[electronic resource] ] : technology, applications, and health / / Sirshendu De, Sourav Mondal and Suvrajit Banerjee
Autore De Sirshendu
Pubbl/distr/stampa Chichester, West Sussex, UK, : Wiley Wordmark, 2013
Descrizione fisica 1 online resource (244 p.)
Disciplina 664/.5
Altri autori (Persone) MondalSourav
BanerjeeSuvrajit
Soggetto topico Nonnutritive sweeteners
Sweeteners
ISBN 1-118-35071-5
1-118-35072-3
1-118-35069-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Stevioside; Copyright; Contents; Authors' biographies; Preface; Acknowledgements; List of figures; List of tables; 1 Introduction to stevioside; 1.1 History of Stevia; 1.2 Composition of Stevia; 1.3 Source of stevioside; 1.4 Physicochemical and biological properties of steviol glycosides; 1.5 Analysis of stevioside (steviol glycosides) and Stevia extract; References; 2 Health benefits and pharmacological effects of steviol glycosides; 2.1 Effect of stevioside in absorption, distribution, metabolism and excretion; 2.2 Antihyperglycaemic effect; 2.3 Antihypertensive effect
2.4 Anti-inflammatory effect2.5 Anticarcinogenic antitumour effects; 2.6 Antioxidant activity; 2.7 Antimicrobial and antidiarrhoeal effects; 2.8 Effect on renal function; References; 3 Applications of stevioside; References; 4 Conventional extraction processes of stevioside; 4.1 Ion exchange; 4.2 Solvent extraction; 4.3 Extraction by chelating agents; 4.4 Adsorption and chromatographic separation; 4.5 Ultrasonic extraction; 4.6 Microwave-assisted extraction; 4.7 Supercritical fluid extraction; References; 5 Brief introduction to pressure-driven membrane-based processes
5.1 Advantages of the membrane-based process5.2 Classification of the processes; 5.2.1 Reverse osmosis; 5.2.2 Nanofiltration; 5.2.3 Ultrafiltration; 5.2.4 Microfiltration; 5.3 Characterisation of membranes; 5.3.1 Membrane permeability (Lp); 5.3.2 Retention; 5.3.3 Molecular weight cut-off; 5.4 Membrane modules (Bungay et al. 1986; Ho and Sirkar 1992; Rautenbach and Albrecht 1986); 5.4.1 Plate and frame module; 5.4.2 Tubular module; 5.4.3 Hollow-fibre module; 5.4.4 Spiral-wound module; 5.5 Limitations; 5.5.1 Concentration polarisation; 5.5.2 Membrane fouling and cleaning
5.6 Quantification of concentration polarisation5.6.1 Osmotic pressure-controlled model; 5.6.2 Gel layer controlling model; 5.7 Applications of membrane-based processes; 5.7.1 Reverse osmosis; 5.7.2 Nanofiltration; 5.7.3 Ultrafiltration; 5.7.4 Microfiltration; References; 6 State of the art of stevioside processing using membrane-based filtration; 6.1 Clarification and purification; 6.2 Concentration by nanofiltration; 6.3 Limitations; References; 7 Detailed membrane-based technologies for extraction of stevioside; 7.1 Outline of processing; 7.2 Optimisation of water extraction process
7.2.1 Stevioside7.3 Optimisation of primary clarification (centrifugation or microfiltration); 7.3.1 Colour; 7.3.2 Clarity; 7.3.3 Total solids; 7.3.4 Stevioside; 7.3.5 Optimisation; 7.3.6 Microfiltration; 7.3.7 Comparison; 7.4 Selection of membrane; 7.5 Optimisation of operating conditions; 7.6 Mechanism of flux decline; 7.6.1 Characteristic flux decline profile; 7.6.2 Response surface model; 7.7 Ultrafiltration of primary clarified Stevia extract; 7.7.1 Unstirred batch cell studies; 7.7.2 Stirred batch cell studies; 7.7.3 Cross-flow ultrafiltration; 7.8 Concentration by nanofiltration
References
Record Nr. UNINA-9910139031203321
De Sirshendu  
Chichester, West Sussex, UK, : Wiley Wordmark, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Stevioside : technology, applications, and health / / Sirshendu De, Sourav Mondal and Suvrajit Banerjee
Stevioside : technology, applications, and health / / Sirshendu De, Sourav Mondal and Suvrajit Banerjee
Autore De Sirshendu
Edizione [1st ed.]
Pubbl/distr/stampa Chichester, West Sussex, UK, : Wiley Wordmark, 2013
Descrizione fisica 1 online resource (244 p.)
Disciplina 664/.5
Altri autori (Persone) MondalSourav
BanerjeeSuvrajit
Soggetto topico Nonnutritive sweeteners
Sweeteners
ISBN 1-118-35071-5
1-118-35072-3
1-118-35069-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Stevioside; Copyright; Contents; Authors' biographies; Preface; Acknowledgements; List of figures; List of tables; 1 Introduction to stevioside; 1.1 History of Stevia; 1.2 Composition of Stevia; 1.3 Source of stevioside; 1.4 Physicochemical and biological properties of steviol glycosides; 1.5 Analysis of stevioside (steviol glycosides) and Stevia extract; References; 2 Health benefits and pharmacological effects of steviol glycosides; 2.1 Effect of stevioside in absorption, distribution, metabolism and excretion; 2.2 Antihyperglycaemic effect; 2.3 Antihypertensive effect
2.4 Anti-inflammatory effect2.5 Anticarcinogenic antitumour effects; 2.6 Antioxidant activity; 2.7 Antimicrobial and antidiarrhoeal effects; 2.8 Effect on renal function; References; 3 Applications of stevioside; References; 4 Conventional extraction processes of stevioside; 4.1 Ion exchange; 4.2 Solvent extraction; 4.3 Extraction by chelating agents; 4.4 Adsorption and chromatographic separation; 4.5 Ultrasonic extraction; 4.6 Microwave-assisted extraction; 4.7 Supercritical fluid extraction; References; 5 Brief introduction to pressure-driven membrane-based processes
5.1 Advantages of the membrane-based process5.2 Classification of the processes; 5.2.1 Reverse osmosis; 5.2.2 Nanofiltration; 5.2.3 Ultrafiltration; 5.2.4 Microfiltration; 5.3 Characterisation of membranes; 5.3.1 Membrane permeability (Lp); 5.3.2 Retention; 5.3.3 Molecular weight cut-off; 5.4 Membrane modules (Bungay et al. 1986; Ho and Sirkar 1992; Rautenbach and Albrecht 1986); 5.4.1 Plate and frame module; 5.4.2 Tubular module; 5.4.3 Hollow-fibre module; 5.4.4 Spiral-wound module; 5.5 Limitations; 5.5.1 Concentration polarisation; 5.5.2 Membrane fouling and cleaning
5.6 Quantification of concentration polarisation5.6.1 Osmotic pressure-controlled model; 5.6.2 Gel layer controlling model; 5.7 Applications of membrane-based processes; 5.7.1 Reverse osmosis; 5.7.2 Nanofiltration; 5.7.3 Ultrafiltration; 5.7.4 Microfiltration; References; 6 State of the art of stevioside processing using membrane-based filtration; 6.1 Clarification and purification; 6.2 Concentration by nanofiltration; 6.3 Limitations; References; 7 Detailed membrane-based technologies for extraction of stevioside; 7.1 Outline of processing; 7.2 Optimisation of water extraction process
7.2.1 Stevioside7.3 Optimisation of primary clarification (centrifugation or microfiltration); 7.3.1 Colour; 7.3.2 Clarity; 7.3.3 Total solids; 7.3.4 Stevioside; 7.3.5 Optimisation; 7.3.6 Microfiltration; 7.3.7 Comparison; 7.4 Selection of membrane; 7.5 Optimisation of operating conditions; 7.6 Mechanism of flux decline; 7.6.1 Characteristic flux decline profile; 7.6.2 Response surface model; 7.7 Ultrafiltration of primary clarified Stevia extract; 7.7.1 Unstirred batch cell studies; 7.7.2 Stirred batch cell studies; 7.7.3 Cross-flow ultrafiltration; 7.8 Concentration by nanofiltration
References
Record Nr. UNINA-9910821464803321
De Sirshendu  
Chichester, West Sussex, UK, : Wiley Wordmark, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui